Abstract
This case concerns Bio3 Research, a small biotechnology company established in Italy in
2001 that focuses on cardiovascular disorders, connective tissue regeneration, and renal
disorders. The case reports on Dr. Pilato, founder and chief executive officer of Bio3
Research, while reflecting with his chief operating officer on the investments required to
finance his patents and products pipeline. The case offers a discussion around the entrepreneurial
process of Bio3 Research, from opportunity identification to opportunity development
and exploitation. The case then reveals Bio3 Research’s business model and
examines its activities and management practices in the patent market. In a recessive world
economy, Bio3 Research has an exciting portfolio of patents and products in high-growth
markets but must decide between financial options, as the company cannot exploit all of
these opportunities on its own.
Lingua originale | English |
---|---|
pagine (da-a) | 1247-1264 |
Numero di pagine | 18 |
Rivista | Entrepreneurship Theory and Practice |
Volume | 39 |
DOI | |
Stato di pubblicazione | Pubblicato - 2015 |
Keywords
- Business model